DecisionDx®-SCC Scientific References

Wysong A, Newman JG, Covington KR, et al. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2020. doi:https://doi.org/10.1016/j.jaad.2020.04.088


Ibrahim SF, Kasprzak J, Hall MA, et al. Improved cutaneous squamous cell carcinoma metastasis risk assessment, submitted.


Data on file, Castle Biosciences.

Farberg AS, Hall MA, Douglas L, et al. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: Impact on patient management. Curr Med Res Opin 2020. doi:10.1080/03007995.2020.1763284


Litchman GH, Fitzgerald AL, Kurley SJ, et al. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. Curr Med Res Opin 2020. doi:10.1080/03007995.2020.1763283


Teplitz R, Prado G, Litchman GB, Rigel DS. Impact of gene expression profile testing on the management of squamous cell carcinoma by dermatologistsJ Drugs Dermatol 2019;18:980-4.

SEER data release 2019.


Mansouri B, Housewright CD. The treatment of actinic keratoses— the rule rather than the exception. JAMA Dermatol 2017;153:1200.


Order DecisionDx-SCC

For Information

Call: 866-788-9007

What's Next?

DecisionDx®-UM Overview

How Do You Get a
DecisionDx-SCC Test?

Scroll to Top